Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.858
-0.182 (-5.97%)
Jan 29, 2026, 1:33 PM EST - Market open
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $75.76 million as of January 29, 2026. Its market cap has increased by 15.11% in one year.
Market Cap
75.76M
Enterprise Value
65.28M
1-Year Change
15.11%
Ranking
Category
Stock Price
$2.86
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from $62.51M to $75.76M, an increase of 21.19%. That is a compound annual growth rate of 3.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 80.57M | -12.14% |
| Dec 31, 2025 | 91.70M | 32.13% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALX Oncology Holdings | 79.70M |
| Pliant Therapeutics | 79.27M |
| Mereo BioPharma Group | 77.75M |
| CalciMedica | 76.37M |
| Coeptis Therapeutics Holdings | 76.11M |
| PolyPid | 75.69M |
| Equillium | 75.51M |
| Gain Therapeutics | 74.73M |